Back to Blog
Women's Health
women's health
menopause
hormones

Concierge Medicine for Women's Health

Women's hormonal health (perimenopause, menopause, thyroid, PCOS, adrenal issues) gets under-served in 15-minute appointments. Here's what thorough evaluation actually requires, the current evidence on menopause hormone therapy, and how I approach it clinically.

Dr. Ben SofferJanuary 10, 20268 min read
Concierge Medicine for Women's Health

There's a well-documented gap between the hormonal health care women need and what traditional primary care delivers. It's not a matter of individual physicians not caring; it's that the 15-minute appointment structure makes thorough hormonal evaluation nearly impossible.

Consider what perimenopausal or thyroid evaluation actually requires: a detailed symptom history, nuanced interpretation of labs in clinical context, a discussion of treatment options (bioidentical hormones versus conventional HRT versus lifestyle versus thyroid optimization), ongoing monitoring, and adjustment based on response. That's a 45-minute conversation at minimum, and it needs to happen repeatedly as symptoms evolve.

In a concierge practice, that conversation actually happens. Here's how I approach women's hormonal health and what the current evidence supports.

TL;DR

  • Perimenopause/menopause, thyroid disorders, and PCOS need longitudinal attention that 15-minute primary care visits structurally can't provide
  • Modern menopausal hormone therapy (MHT) has a favorable benefit/risk profile for most healthy women under 60 within 10 years of menopause; the post-WHI overcaution is outdated per NAMS, the Endocrine Society, and ACOG
  • Thorough thyroid workup uses full panels (TSH, free T4, free T3, reverse T3, TPO + thyroglobulin antibodies), not just TSH
  • Initial hormonal consultation in this practice is 60 to 90 minutes; follow-ups give time for real symptom and dose evolution
  • This is preventive medicine: estrogen deficiency and untreated hypothyroidism have decades-long cardiovascular, bone, and cognitive consequences
  • To reach the practice: call 561-468-6981

The common gaps

The hormonal transitions affecting women (perimenopause, menopause, thyroid dysfunction, PCOS, adrenal dysregulation) share certain features: complex, individualized, evolving over time. They require longitudinal attention rather than single-visit management.

Perimenopause and menopause

Perimenopause can begin up to 10 years before the last menstrual period, often in the early to mid 40s. Symptoms are notoriously variable: irregular periods, sleep disruption, mood changes, brain fog, joint pain, reduced libido, vaginal dryness, weight gain, and more. Many women spend years having these symptoms attributed to anxiety, depression, or stress before anyone considers the hormonal picture. (Mental health symptoms in midlife specifically deserve hormonal evaluation as part of the workup, not just psychiatric treatment in isolation.)

The 2002 Women's Health Initiative study created a generation of physicians overcautious about menopausal hormone therapy (MHT). Subsequent data and updated guidelines from NAMS, the Endocrine Society, and ACOG have substantially revised that picture. For most healthy women under 60 who are within 10 years of menopause onset, MHT has a favorable benefit-to-risk profile. Navigating this decision requires a physician who's read the updated literature and has time to discuss it.

Thyroid disorders

Thyroid dysfunction affects women at roughly 5 to 8 times the rate of men. Hypothyroidism specifically is under-diagnosed. A standard TSH screening misses many patients with subclinical or functional thyroid issues who nonetheless have significant symptoms.

A thorough thyroid workup includes full panels (TSH, free T4, free T3, reverse T3, thyroid antibodies including TPO and thyroglobulin antibodies), clinical correlation with symptoms, and willingness to treat based on the complete picture rather than a single number.

PCOS and related metabolic disorders

Polycystic ovary syndrome affects approximately 1 in 10 women of reproductive age and is one of the most common endocrine disorders in medicine. Management involves insulin resistance, androgen excess, menstrual irregularity, and fertility concerns. It requires coordinated, ongoing attention that traditional primary care rarely provides.

How I approach women's hormonal health

The evaluation needs to actually be comprehensive:

Baseline testing. Full hormone panel including sex hormones (estradiol, progesterone, testosterone, SHBG, DHEA-S, FSH/LH where relevant), thyroid panel as above, adrenal markers (cortisol timing, DHEA-S), metabolic markers (fasting insulin, A1C), lipid panel with particle analysis, vitamin D, and inflammatory markers. Not just TSH and estradiol. (What an executive-level physical actually includes for the broader cardiovascular and metabolic picture.)

Symptom-correlated interpretation. Lab values get interpreted in the context of your symptoms, history, and life stage. Population reference ranges don't always apply to the individual patient, particularly in perimenopause.

Time for the conversation. The initial hormonal consultation takes a full visit, typically 60 to 90 minutes, to understand the complete picture. Follow-ups allow time to discuss what's changing, what's working, and what needs adjustment.

Personalized treatment planning. The right approach might be lifestyle modification, bioidentical hormone therapy, conventional HRT, thyroid optimization, or some combination. The plan gets tailored to your values, preferences, and clinical picture.

Longitudinal monitoring. Hormonal transitions don't resolve in one visit. Symptoms evolve, doses need adjusting, new developments arise. A concierge relationship accommodates this rhythm. (Direct cell phone access between visits is part of how that actually works.)

The menopause hormone therapy question

Given the history of HRT controversy, many women arrive uncertain whether hormone therapy is appropriate for them. The current evidence supports MHT for most women experiencing significant menopausal symptoms who are:

  • Within 10 years of menopause onset (or under 60 years old)
  • Without specific contraindications: personal history of breast cancer, active cardiovascular disease, history of certain clotting disorders, unexplained vaginal bleeding

The conversation about whether, when, and how to use hormone therapy depends on your symptom burden, personal history, family history, and preferences. It's a real conversation, not a 15-minute decision.

Options include estradiol patches, oral estradiol, topical formulations, compounded bioidentical hormones, combination therapies with progesterone for women with intact uterus, and newer options like non-hormonal treatments (fezolinetant) for patients who can't or won't use hormones. Each has tradeoffs.

Women's health beyond hormones

A thoughtful approach to women's health in midlife also covers:

Bone health. Appropriate osteoporosis risk assessment, DEXA scanning at the right intervals, calcium and vitamin D optimization, fracture prevention strategies.

Cardiovascular risk. Women's cardiovascular risk differs from men's in meaningful ways and is often under-recognized. Presenting symptoms are different, risk factor weights differ, and some women's cardiac events get missed because the presentation doesn't match the classic male pattern. Cardiovascular risk assessment should be specific rather than generic.

Mental health. Hormonal fluctuations meaningfully affect mood and cognition. Depression, anxiety, and cognitive symptoms that emerge during perimenopause deserve hormonal evaluation as part of the workup, not just psychiatric treatment in isolation.

Sleep. Poor sleep during menopause isn't just a quality-of-life issue. It has cardiovascular, metabolic, and cognitive consequences. Addressing sleep is part of the hormonal picture.

Why this matters long-term

The consequences of under-treated hormonal issues aren't just symptomatic. Long-term estrogen deficiency is associated with accelerated cardiovascular disease, osteoporosis, cognitive decline, and genitourinary dysfunction. Untreated hypothyroidism increases cardiovascular and metabolic risk. These aren't cosmetic concerns.

Good hormonal care in midlife is preventive medicine. Getting it right in your 40s and 50s pays dividends for the following three decades.

Frequently Asked Questions

Do you replace my OB/GYN?

No. For most women, primary care manages the medical and hormonal aspects (thyroid, perimenopause, MHT, metabolic, cardiovascular), and the OB/GYN handles the gynecologic exam, cervical screening, and any pelvic-floor or surgical needs. In a concierge model, the physician coordinates with your OB/GYN directly so the care plan is unified rather than fragmented.

Do you prescribe HRT, including bioidentical hormones?

Yes, for appropriate patients. Decisions involve symptom burden, personal/family history, contraindications, and your preferences about route (patch, oral, topical) and formulation (FDA-approved versus compounded bioidentical). The 60 to 90 minute initial consultation is what makes the actual conversation possible; the prescription is the easy part.

What's the difference between bioidentical and conventional HRT?

"Bioidentical" means molecularly identical to human hormones. Many FDA-approved hormone therapies (estradiol, micronized progesterone) are themselves bioidentical. The contested category is compounded bioidentical hormones (cBHT) prepared by a compounding pharmacy in non-standardized doses. Some patients benefit from cBHT; some are better served by FDA-approved formulations. The decision is patient-specific and involves a real conversation about evidence, dose precision, and your preferences.

What age should I start thinking about hormonal evaluation?

Mid-40s for perimenopause considerations; earlier if you have symptoms that suggest hormonal disruption (severe PMS, fatigue out of proportion to lifestyle, weight changes that don't track diet/exercise, mood changes with cyclic patterns). Don't wait for periods to fully stop; perimenopausal symptoms often start years before that.

What about women on Medicare?

The hormonal care described above is primary-care-level work. Medicare covers the medical visits and labs as it does for any other primary care; the concierge membership covers the access and time. (Full breakdown of how concierge medicine works alongside Medicare.)

If you've felt dismissed

If you've felt dismissed, rushed, or inadequately addressed in your hormonal health care, or if symptoms are being attributed to anxiety when you suspect something hormonal is happening, a concierge practice may be a better fit. (Questions worth asking any concierge practice you're evaluating.)

For more on concierge medicine generally, see is concierge medicine worth it and the broader women's-health-friendly evaluation criteria.

About the Author

Dr. Ben Soffer, DO is a board-certified physician practicing concierge primary care in Boca Raton, Florida. He caps his practice at 50 patients, which is what makes the time and longitudinal attention that women's hormonal health actually requires structurally possible.

If you want to talk

A no-obligation conversation about your specific situation.

Frequently Asked Questions

Do you replace my OB/GYN?
No. For most women, primary care manages the medical and hormonal aspects (thyroid, perimenopause, MHT, metabolic, cardiovascular), and the OB/GYN handles the gynecologic exam, cervical screening, and any pelvic-floor or surgical needs. In a concierge model, the physician coordinates with your OB/GYN directly so the care plan is unified rather than fragmented.
Do you prescribe HRT, including bioidentical hormones?
Yes, for appropriate patients. Decisions involve symptom burden, personal/family history, contraindications, and your preferences about route (patch, oral, topical) and formulation (FDA-approved versus compounded bioidentical). The 60 to 90 minute initial consultation is what makes the actual conversation possible; the prescription is the easy part.
What's the difference between bioidentical and conventional HRT?
'Bioidentical' means molecularly identical to human hormones. Many FDA-approved hormone therapies (estradiol, micronized progesterone) are themselves bioidentical. The contested category is compounded bioidentical hormones (cBHT) prepared by a compounding pharmacy in non-standardized doses. Some patients benefit from cBHT; some are better served by FDA-approved formulations. The decision is patient-specific and involves a real conversation about evidence, dose precision, and your preferences.
What age should I start thinking about hormonal evaluation?
Mid-40s for perimenopause considerations; earlier if you have symptoms that suggest hormonal disruption (severe PMS, fatigue out of proportion to lifestyle, weight changes that don't track diet/exercise, mood changes with cyclic patterns). Don't wait for periods to fully stop; perimenopausal symptoms often start years before that.
What about women on Medicare?
The hormonal care described above is primary-care-level work. Medicare covers the medical visits and labs as it does for any other primary care; the concierge membership covers the access and time.
women's health
menopause
hormones
concierge medicine
Dr. Ben Soffer, DO

Dr. Ben Soffer

Board Certified Internal Medicine

Dr. Ben Soffer is a board-certified Doctor of Osteopathic Medicine providing concierge internal medicine care across Palm Beach County, Florida.

Learn more about Dr. Soffer

Concierge Medicine

Considering a concierge primary care relationship?

Schedule a free consultation with Dr. Ben Soffer, DO — board-certified internal medicine in Boca Raton.

Book Free Consultation

Have Questions About Your Health?

Schedule a consultation with Dr. Soffer to discuss your health concerns and learn how concierge care can help.